Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events

by Thomas Hansen, John Wilding, Michel Marre, Stanislava Macura, Michael A Nauck, Raymond de la Rosa, Vincent Woo, Emre Yildirim
Published 2020-12-01